Physician profile
Olivia Masterson
NPI 1306572094
$1,347.55
in general payments reported to CMS, 2019-2025
16 companies · $1,066 in 2025
The $1,066 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $282 · 2025: $1,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,347.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $440.34 | 2025 | |
| Lilly USA, LLC | $253.33 | 2024-2025 | Kisunla, Amyvid |
| Otsuka America Pharmaceutical, INC. | $166.23 | 2024-2025 | Rexulti |
| Lundbeck LLC | $101.41 | 2024-2025 | Vyepti, Rexulti |
| Novartis Pharmaceuticals Corporation | $63.82 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $50.08 | 2025 | Austedo Xr |
| Abbvie INC. | $39.18 | 2024-2025 | |
| Harmony Biosciences LLC | $37.34 | 2024-2025 | |
| Acadia Pharmaceuticals INC | $35.83 | 2025 | Nuplazid |
| Astrazeneca Pharmaceuticals LP | $31.96 | 2024 | Wainua |
| C2n Diagnostics, LLC | $27.71 | 2025 | Precivityad2 |
| Amneal Pharmaceuticals LLC | $23.17 | 2025 | Crexont |
| Ipsen Biopharmaceuticals, INC | $22.60 | 2024 | Dysport |
| Csl Behring | $18.63 | 2025 | Hizentra |
| Supernus Pharmaceuticals, INC. | $18.26 | 2025 | Qelbree |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $17.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Masterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.